Interference of Monoclonal Gammopathy with Fibrinogen Assay Producing Spurious Dysfibrinogenemia

Abstract

Abnormal coagulation properties indicative of a dysfibrinogenemia were found in the plasma of an asymptomatic 65-year-old male. An immunoglobulin k light chain was found to interfere with Fg functional assay and coagulation tests (activated partial thromboplastin time, prothrombin time, and thrombin time). Steroid therapy reduced the inhibitory effect (after dexamethasone treatment coagulation test and functional Fg value normalized). Spurious dysfibrinogenemia associated with light chain monoclonal gammopathy of undetermined significance was diagnosed.

Keywords

coagulation factors - inhibitor - fibrinogen - fibrin

• References

• 1 Mosesson MW. The roles of fibrinogen and fibrin in hemostasis and thrombosis. Semin Hematol 1992; 29 (03) 177-188
• 2 Casini A, Blondon M, Tintillier V. , et al. Mutational epidemiology of congenital fibrinogen disorders. Thromb Haemost 2018; 118 (11) 1867-1874
• 3 Casini A, Blondon M, Lebreton A. , et al. Natural history of patients with congenital dysfibrinogenemia. Blood 2015; 125 (03) 553-561
• 4 Mammen EF. Coagulation defects in liver disease. Med Clin North Am 1994; 78 (03) 545-554
• 5 Post GR, James L, Alapat D, Guillory V, Cottler-Fox M, Nakagawa M. A case of acquired dysfibrinogenemia in multiple myeloma treated with therapeutic plasma exchange. Transfus Apheresis Sci 2013; 48 (01) 35-38
• 6 National Committee for Clinical Laboratory Standards. NCCLS Document H30-A: Procedure for the Determination of Fibrinogen in Plasma; Approved Guideline. Villanova, PA: National Committee for Clinical Laboratory Standards; 1994
• 7 Palareti G, Maccaferri M, Manotti C. , et al; C.I.S.M.E.L. Comitato Italiano per la Standardizzazione dei Metodi in Ematologia e Laboratorio. Fibrinogen assays: a collaborative study of six different methods. Clin Chem 1991; 37 (05) 714-719
• 8 Dear A, Brennan SO, Sheat MJ, Faed JM, George PM. Acquired dysfibrinogenemia caused by monoclonal production of immunoglobulin λ light chain. Haematologica 2007; 92 (11) e111-e117
• 9 Llobet D, Borrell M, Vila L, Vallvé C, Felices R, Fontcuberta J. An acquired inhibitor that produced a delay of fibrinopeptide B release in an asymptomatic patient. Haematologica 2007; 92 (02) e17-e19
• 10 Kotlín R, Sobotková A, Riedel T. , et al. Acquired dysfibrinogenemia secondary to multiple myeloma. Acta Haematol 2008; 120 (02) 75-81